U.S. Paper and Forestry Products Stock News

MSC Industrial Direct (MSM) opened fiscal Q1 2026 with total revenue of US$965.7 million and basic EPS of US$0.93, alongside net income excluding extra items of US$51.8 million, providing an updated view of how its margins are holding up. Over recent quarters, the company has reported revenue of US$952.3 million in Q4 2024, US$928.5 million in Q1 2025, and US$965.7 million in Q1 2026. EPS over the same periods was US$0.99, then US$0.83, and now US$0.93, which puts the latest results in...

Some investors are considering whether Toro's current share price aligns with its underlying worth, or if recent market interest has pushed it away from that level. Toro's stock has recently traded at US$87.87, with returns of 11.6% over the last 7 days, 26.1% over 30 days, 9.6% year to date, 13.2% over 1 year, but declines of 20.0% over 3 years and 5.3% over 5 years. Recent attention on Toro has focused on how its long-term share performance compares with shorter-term gains, which has put...

If you are wondering whether General Motors stock still offers value at current levels, you are not alone. This article focuses squarely on that question. GM shares last closed at US$85.13, with returns of 4.7% over 7 days, 10.3% over 30 days, 5.1% year to date, 68.7% over 1 year and 129.2% over 3 years, compared to 71.2% over 5 years. Recent headlines around General Motors have focused on its ongoing transition toward electric and software enabled vehicles, along with industry wide...

Wayland exit puts HNI’s manufacturing footprint in focus HNI (HNI) has drawn fresh investor attention after announcing plans to exit its Wayland, New York, manufacturing facility by 2027. The company will consolidate production into other North American plants to pursue efficiency and cost savings. See our latest analysis for HNI. The Wayland exit comes as HNI’s 7-day share price return of 3.83% and 30-day share price return of 7.20% suggest near term momentum, while its 1-year total...

Prologis (PLD) is back in focus after new data flagged it as the REIT sector’s largest projected dividend payer for 2026, with an expected payout of about $4.3b and approximately 10% year-on-year growth. See our latest analysis for Prologis. Recent dividend headlines arrive as Prologis’ share price, now at $128.39, has logged a 15.43% 90 day share price return, while its 1 year total shareholder return of 26.03% and 5 year total shareholder return of 54.65% point to momentum that has been...

If you are wondering whether CubeSmart's current share price lines up with its underlying worth, you are not alone. This article is built to help you frame that question clearly. The stock most recently closed at US$37.06, with returns of 2.8% over 7 days, 4.2% over 30 days, 4.7% year to date, while the last 1 year shows a 5.5% decline and the 5 year return sits at 35.7%. Recent coverage of CubeSmart has focused on its position in the self storage real estate space and how investors are...

BeOne Medicines stock: first look at recent performance BeOne Medicines (ONC) has drawn fresh attention after its recent trading session, with the share price closing at $320.37 and short term returns showing mixed moves over the past week, month, and past 3 months. See our latest analysis for BeOne Medicines. Despite the 1-day share price return of a 4.04% decline taking the stock to $320.37, the 1-year total shareholder return of 80.10% points to strong longer term momentum that currently...

Why LPL Financial Holdings (LPLA) is drawing fresh attention LPL Financial Holdings (LPLA) is back on investor watchlists after recent share price moves, with short term returns contrasting against longer term gains and raising questions about how its current valuation lines up with fundamentals. See our latest analysis for LPL Financial Holdings. At a share price of $362.36, LPL Financial Holdings has seen short term share price momentum cool, with a 30 day share price return of a 3.30%...

Ormat Technologies has begun commercial operations at its Arrowleaf hybrid solar-plus-storage project in California, a 42 MW solar and 35 MW/140 MWh storage facility operating under a long-term tolling agreement with San Diego Community Power to serve nearly 1 million customers. The project also showcases Ormat’s approach to capital efficiency by monetizing investment tax credits through a hybrid tax equity partnership with Morgan Stanley Renewables that generated about US$38 million in...

Investors may be wondering whether McEwen at around US$20.49 is still offering value after a strong run, or if most of the easy upside is already reflected in the share price. The stock has recent returns of 10.7% over 7 days, 5.9% over 30 days, 9.7% year to date, 145.7% over 1 year, 188.2% over 3 years and 109.1% over 5 years. This naturally raises questions about how its current price lines up with its fundamentals. Recent coverage has focused on McEwen's role in the materials space and...

CMS Energy (CMS) is back in focus after Consumers Energy began operating Muskegon Solar, a 250 megawatt project on 1,900 acres that is sized to supply electricity for about 40,000 Michigan homes and businesses. See our latest analysis for CMS Energy. At a share price of $69.85, CMS Energy has seen a 5.7% decline in its 90 day share price return, while its 1 year total shareholder return of 8.6% indicates steadier long term momentum. Recent renewable projects like Muskegon Solar may influence...

For investors considering whether Eastern Bankshares, at around US$19.43, is offering value right now or whether the easy gains are already behind it, this article is designed to help answer that question using clear valuation checks. The stock has returned 5.4% over the past 7 days, 0.6% over the last 30 days, 4.8% year to date, 16.8% over 1 year and 18.7% over 3 years, with a 5 year return of 33.7%. Recent moves in the share price sit against a backdrop of ongoing coverage of US regional...

United Therapeutics (UTHR) is drawing investor attention after recent share price moves, with the stock down 2.6% over the past day but showing gains over the past month and the past 3 months. See our latest analysis for United Therapeutics. While the share price is currently US$490.83 and the 1 day share price return is a 2.6% decline, the 90 day share price return of 11.6% and 1 year total shareholder return of 33.9% suggest momentum has been building over the longer stretch, even if...

If you are wondering whether Five9 is starting to look mispriced after a long slide in its share price, you are not alone. This article is going to focus squarely on what the numbers say about value. The stock last closed at US$19.90, with returns of a 0.7% decline over 7 days, a 7.5% decline over 30 days, a 5.8% gain year to date, and a 48.9% decline over the last year, extending a 72.1% decline over 3 years and an 88.4% decline over 5 years. These moves have kept Five9 on the radar for...

Viridian Therapeutics (VRDN) is in focus after the FDA accepted its Biologics License Application for veligrotug in thyroid eye disease under Priority Review, while multiple late stage programs and pipeline updates continue to attract investor attention. See our latest analysis for Viridian Therapeutics. Despite a softer patch recently, with a 30 day share price return of 4.62% and a 7 day share price return of 2.54%, Viridian’s 90 day share price return of 44.50% and 1 year total shareholder...

Teleflex Incorporated recently appointed long-time board member Stuart Randle as interim President and CEO, replacing Liam Kelly, and at the same time issued preliminary 2025 revenue guidance of about US$3.27 billion, slightly below its prior outlook due to softer demand in certain product lines and delayed orders. This combination of leadership transition and reduced sales expectations raises fresh questions about Teleflex’s near-term execution while spotlighting the depth of Randle’s...

PANTHERx Rare Pharmacy and Savara Inc. recently announced an exclusive U.S. distribution agreement for MOLBREEVI, following Savara’s December 2025 BLA submission to the FDA for treating autoimmune PAP with a Priority Review request. The partnership positions PANTHERx’s specialized rare-disease pharmacy network and support services as a ready-made commercial channel if MOLBREEVI secures regulatory approval. We’ll now examine how the exclusive PANTHERx distribution partnership for MOLBREEVI...

M&T Bank (MTB) has drawn attention after its recent share performance, with the stock up 1.9% on the day and positive total returns over the past year and the past 3 months. See our latest analysis for M&T Bank. That 1.9% move in the share price to $213.61 comes on top of an 8.1% 30 day share price return and an 18.1% 90 day share price return, while the 1 year total shareholder return of 15.1% points to momentum that has been building rather than fading. If M&T Bank’s recent run has you...

Recent commentary highlights that Enova International has been growing revenue, managing credit risk with data-driven underwriting, diversifying through acquisitions, and returning cash to shareholders, reinforcing its profile as a steady fintech lender serving consumers and small businesses often overlooked by traditional banks. An interesting aspect is how Enova’s proprietary AI- and machine-learning-based credit models, combined with easing lending conditions, are viewed as supporting...

Simon Property Group’s operating partnership recently agreed to issue US$800 million of 4.300% senior notes due 2031, with closing expected on January 13, 2026, to repay an equal amount of 3.300% notes that matured in 2026. The refinancing highlights Simon’s focus on reshaping its liability profile at a higher coupon amid concerns around leverage, liquidity, and overall balance sheet resilience. We’ll now examine how this US$800 million refinancing at a 4.300% coupon could influence Simon...

On December 29, 2025, Alignment Healthcare’s Chief Information Officer Robert L. Scavo sold 69,541 shares worth about US$1.3 million, representing just over 12% of his direct holdings in a tax-driven transaction that did not involve options, derivatives, or indirect entities. While this insider sale stemmed from personal tax considerations, it comes alongside recent contract wins and strong operational execution that have reinforced Alignment Healthcare’s business momentum. Next, we’ll...

B. Riley’s decision to resume coverage of Ladder Capital (LADR), together with the company’s latest quarterly dividend declaration, has put fresh attention on this commercial real estate lender’s income profile and credit trajectory. See our latest analysis for Ladder Capital. At a share price of $10.79, Ladder Capital has had a mixed year, with a 3.35% 90 day share price return and a 6.27% 1 year total shareholder return that points to gradually improving momentum as investors reassess...

Rithm Capital (RITM) has come back into focus after recent share price swings tied to changing interest rate expectations, with the next earnings report and a declared dividend now front and center for investors. See our latest analysis for Rithm Capital. Those recent swings around interest rate headlines sit against a steadier picture, with the share price at $11.39 and a 90 day share price return of 6.95% alongside a 1 year total shareholder return of 13.64%. This suggests that momentum has...

Mach Natural Resources (MNR) drew investor attention after Stifel reaffirmed its Buy rating while trimming expectations in response to softer commodity markets, quarterly results, and anticipated capital spending trends. See our latest analysis for Mach Natural Resources. The Stifel update and recent board changes have come against a softer backdrop for Mach Natural Resources, with the latest share price at $11.05, a 30 day share price return of a 9.57% decline and a 1 year total shareholder...